15 Feb 2026
New horizons in structural heart disease therapy - Cutting-edge stroke prevention devices: WATCHMAN × SENTINEL
Sponsored by Boston Scientific
Spokesperson:
M. Asami
Discussant:
D. Hachinohe
Summary
This session delves into the advances in stroke prevention for patients undergoing TAVI with atrial fibrillation, focusing on left atrial appendage closure (LAAC) and cerebral protection strategies. It highlights the evolving role of WATCHMAN devices and the SENTINEL Cerebral Protection System, emphasising perioperative stroke risk management and current guidelines for safe clinical application.
Learning Objectives
- To learn about LAAC as a new therapy for stroke prevention after TAVI in patients with atrial fibrillation, and the importance of stroke prevention during the perioperative phase of TAVI
- To know the latest insights on LAAC device evolution and post-procedural anticoagulation therapy
- To learn about the need for stroke prevention during TAVI perioperatively and the potential of the SENTINEL Cerebral Protection System, guidelines for appropriate use for safe implementation, and considerations for its application in actual clinical practice